Director/PDMR Shareholding

RNS Number : 8614I

Hikma Pharmaceuticals Plc

13 August 2019

 

Notification and public disclosure of transactions by persons discharging managerial responsibilities

Khalid Nabilsi

1	Details of the person discharging managerial responsibilities / person closely associated
a)	Name	Khalid Nabilsi
2	Reason for the notification
a)	Position/status	Chief Financial Officer
b)	Initial notification /Amendment	Initial notification
3	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)	Name	Hikma Pharmaceuticals PLC
b)	LEI	549300BNS685UXH4JI75
4	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the financial instrument, type of instrument and identification code	Description: Ordinary shares of 10 pence each ID Code: GB00B0LCW083
b)	Nature of the transaction	Disposal of 45,000 Ordinary Shares of 10 pence each in Hikma Pharmaceuticals PLC.
c)	Price(s) and volume(s)	Price(s): £19.48 Volume(s): 10,000 Price(s): £19.50 Volume(s): 5,000 Price(s): £19.79 Volume(s): 25,000 Price(s): £19.75 Volume(s): 5,000
d)	Aggregated information	Aggregated volume: 45,000 Price: £19.68 Total: £885,600
e)	Date of the transaction	9 and 12 August 2019
f)	Place of the transaction	London Stock Exchange (XLON)

Bassam Kanaan

1	Details of the person discharging managerial responsibilities / person closely associated
a)	Name	Bassam Kanaan
2	Reason for the notification
a)	Position/status	EVP, Corporate Development and M&A
b)	Initial notification /Amendment	Initial notification
3	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)	Name	Hikma Pharmaceuticals PLC
b)	LEI	549300BNS685UXH4JI75
4	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the financial instrument, type of instrument and identification code	Description: Ordinary shares of 10 pence each ID Code: GB00B0LCW083
b)	Nature of the transaction	Disposal of 84,500 Ordinary Shares of 10 pence each in Hikma Pharmaceuticals PLC.
c)	Price(s) and volume(s)	Price(s): £19.47 Volume(s): 15,000 Price(s): £19.72 Volume(s): 50,000 Price(s): £19.79 Volume(s): 5,000 Price(s): £19.72 Volume(s): 4,500 Price(s): £19.75 Volume(s): 5,000 Price(s): £19.70 Volume(s): 5,000
d)	Aggregated information	Aggregated volume: 84,500 Price: £19.68 Total: £1,662,990
e)	Date of the transaction	9 and 12 August 2019
f)	Place of the transaction	London Stock Exchange (XLON)

Peter Speirs, Company Secretary, Responsible for releasing this announcement

13 August 2019

 

END

 

 

DSHGCGDICBBBGCX